GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
Public ClinicalTrials.gov record NCT00242372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-Week Randomised, Double-Blind, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Insulin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 24-week randomized, double-blind, multi-center, placebo-controlled study of tesaglitazar in patients with type 2 diabetes who are not adequately controlled on insulin (along or in combination with one or more oral antidiabetic agents in addition to diet and lifestyle advice). The study comprises a 3-week enrollment period and a 24-week randomized, double blind, multi-center, placebo-controlled treatment period and a 3-week follow-up. Patients must receive at least 30 units of insulin per day and will continue their current oral antidiabetic treatment regimen throughout the study.
Study identification
- NCT ID
- NCT00242372
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 370 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Mar 2006 (Actual)
- Last update posted
- Apr 22, 2009
2004 – 2006
United States locations
- U.S. sites
- 71
- U.S. states
- 31
- U.S. cities
- 71
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Tuscson | Arizona | — | — |
| Research Site | Fresno | California | — | — |
| Research Site | Greenbrae | California | — | — |
| Research Site | La Jolla | California | — | — |
| Research Site | Northridge | California | — | — |
| Research Site | Riverside | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Santa Monica | California | — | — |
| Research Site | Spring Valley | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | West Hills | California | — | — |
| Research Site | Waterbury | Connecticut | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Palm Harbor | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Augusta | Georgia | — | — |
| Research Site | Dunwoody | Georgia | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Chicago Heights | Illinois | — | — |
| Research Site | Gurnee | Illinois | — | — |
| Research Site | Maywood | Illinois | — | — |
| Research Site | Springfield | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Bethesda | Maryland | — | — |
| Research Site | Cadillac | Michigan | — | — |
| Research Site | Richmond Heights | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | North Las Vegas | Nevada | — | — |
| Research Site | Pahrump | Nevada | — | — |
| Research Site | Dover | New Hampshire | — | — |
| Research Site | Roseland | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | New Hyde Park | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Wilmington | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Kettering | Ohio | — | — |
| Research Site | Toledo | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Medford | Oregon | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Altoona | Pennsylvania | — | — |
| Research Site | Cheswick | Pennsylvania | — | — |
| Research Site | Erie | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Columbia | South Carolina | — | — |
| Research Site | Greer | South Carolina | — | — |
| Research Site | Corpus Christie | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Fort Worth | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Bellevue | Washington | — | — |
| Research Site | Renton | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
| Research Site | Tacoma | Washington | — | — |
| Research Site | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00242372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2009 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00242372 live on ClinicalTrials.gov.